AR121720A1 - COMPOSITIONS COMPRISING A CAS12I2 VARIANT POLYPEPTIDE AND USES THEREOF - Google Patents

COMPOSITIONS COMPRISING A CAS12I2 VARIANT POLYPEPTIDE AND USES THEREOF

Info

Publication number
AR121720A1
AR121720A1 ARP210100825A ARP210100825A AR121720A1 AR 121720 A1 AR121720 A1 AR 121720A1 AR P210100825 A ARP210100825 A AR P210100825A AR P210100825 A ARP210100825 A AR P210100825A AR 121720 A1 AR121720 A1 AR 121720A1
Authority
AR
Argentina
Prior art keywords
cas12i2
variant
polypeptides
compositions
complexes
Prior art date
Application number
ARP210100825A
Other languages
Spanish (es)
Inventor
Tia Marie Ditommaso
Jeffrey Raymond Haswell
Quinton Norman Wessells
Noah Michael Jakimo
Anthony James Garrity
Jason Michael Carte
Colin Alexander Mgaw
Shaorong Chong
Roy Ziblat
David A Scott
Brendan Jay Hilbert
Original Assignee
Arbor Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Biotechnologies Inc filed Critical Arbor Biotechnologies Inc
Publication of AR121720A1 publication Critical patent/AR121720A1/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a polipéptidos Cas12i2 variantes, métodos de producción de los polipéptidos Cas12i2 variantes, procesos para caracterizar los polipéptidos Cas12i2 variantes, células que comprenden los polipéptidos Cas12i2 variantes, y métodos de uso de los polipéptidos Cas12i2 variantes. La invención se refiere además a complejos que comprenden los polipéptidos Cas12i2 variantes, métodos de producción de los complejos, procesos para caracterizar los complejos, células que comprenden los complejos, y métodos de uso de los complejos.The present invention relates to variant Cas12i2 polypeptides, methods of producing variant Cas12i2 polypeptides, processes for characterizing variant Cas12i2 polypeptides, cells comprising variant Cas12i2 polypeptides, and methods of using variant Cas12i2 polypeptides. The invention further relates to complexes comprising the variant Cas12i2 polypeptides, methods of producing the complexes, processes for characterizing the complexes, cells comprising the complexes, and methods of using the complexes.

ARP210100825A 2020-03-31 2021-03-31 COMPOSITIONS COMPRISING A CAS12I2 VARIANT POLYPEPTIDE AND USES THEREOF AR121720A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063002999P 2020-03-31 2020-03-31

Publications (1)

Publication Number Publication Date
AR121720A1 true AR121720A1 (en) 2022-06-29

Family

ID=82401638

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210100825A AR121720A1 (en) 2020-03-31 2021-03-31 COMPOSITIONS COMPRISING A CAS12I2 VARIANT POLYPEPTIDE AND USES THEREOF

Country Status (1)

Country Link
AR (1) AR121720A1 (en)

Similar Documents

Publication Publication Date Title
BR112022019713A2 (en) COMPOSITIONS COMPRISING A CAS12I2 VARIANT POLYPEPTIDE AND USES THEREOF
CO2023013171A2 (en) Compositions comprising a variant polypeptide and uses thereof
CO2019009354A2 (en) Immunoconjugates of an anti-pd-1 antibody with a mutant il-2 or with il-15
CL2021001430A1 (en) Glp-1 compositions and their uses. (request divisional 202000422)
CO2019007092A2 (en) Synthetic immune receptors and methods of using them
UY37410A (en) TRPV4 ANTAGONISTS
UY37456A (en) IMMUNOGLOBULINAS AND ITS USES
DOP2019000290A (en) KINASE INHIBITORS AND USES OF THEM
CL2021003422A1 (en) Anti-il-13ra2 antibodies and uses thereof (divisional 201902323).
MX2020004414A (en) Compounds and use thereof in the expansion of stem cells and/or progenitor cells.
CO2021005509A2 (en) Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
CO2020014515A2 (en) Monospecific and multispecific anti-tmeff2 antibodies and their uses
CL2024000829A1 (en) Solid forms of a ge glyt1 inhibitor
CL2018003212A1 (en) Cosmetic compositions for skin repair.
AR120057A1 (en) NEOANTIGENIC COMPOSITIONS AND THEIR USES
CO2023011697A2 (en) Compositions comprising a variant cas12i4 polypeptide and uses thereof
CO2024000763A2 (en) Compositions and methods of anti-pacap antibodies
CL2021003228A1 (en) Tricyclic compounds and their use
AR106981A1 (en) AN ANTIMICROBIAL COMPOSITION
AR121720A1 (en) COMPOSITIONS COMPRISING A CAS12I2 VARIANT POLYPEPTIDE AND USES THEREOF
BR112022002666A2 (en) INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF REGULATORY T CELLS
CL2020002058A1 (en) Novel pyridinecarboxamides.
CL2019000099A1 (en) Long-term coagulation factor vii and methods to produce it.
CR20170555A (en) METHOD FOR CREATING A COMPOSITE BASED ON MERCURY, COMPOUND BASED ON MERCURY, METHODS OF USE OF THE COMPOSITE BASED ON MERCURY AND USES ON THE COMPOSITE BASED ON MERCURY.
PE20200613A1 (en) IMMUNOGENIC COMPOSITIONS